CCAB partners with ImmunoBiochem to advance breast cancer therapeutic

Image: ImmunoBiochem CEO Anton Neschadim and CCAB CEO Robert Verhagen. Photo: courtesy of Centre for the Commercialization of Antibodies and Biologics.